Revenue | ₹8,407.95Cr |
Net Profits | ₹848.45Cr |
Net Profit Margins | 10.09% |
Aurobindo Pharma Ltd’s revenue jumped 6% since last year same period to ₹8,407.95Cr in the Q2 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 5.42% jump in its revenue since last 3-months.
Aurobindo Pharma Ltd’s net profit jumped 3.8% since last year same period to ₹848.45Cr in the Q2 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 2.87% jump in its net profits since last 3-months.
Aurobindo Pharma Ltd’s net profit margin fell -2.07% since last year same period to 10.09% in the Q2 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated -2.42% fall in its net profit margins since last 3-months.
The revenue for Aurobindo Pharma Ltd in the Q2 results 2025 was ₹8,407.95Cr.
The net profit for Aurobindo Pharma Ltd in the Q2 results 2025 was ₹848.45Cr.
The net profit margin for Aurobindo Pharma Ltd in the Q2 results 2025 was 10.09%.
The revenue for Aurobindo Pharma Ltd in the Q2 results 2024 was ₹7,932.37Cr.
The net profit for Aurobindo Pharma Ltd in the Q2 results 2024 was ₹817.38Cr.
The net profit margin for Aurobindo Pharma Ltd in the Q2 results 2024 was 10.30%.